ZyVersa Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

ZyVersa Therapeutics, Inc. reported Common Stock Shares Outstanding of 8.10 million shares for the year ending 2025.

  • ZyVersa Therapeutics, Inc. showed an increase of +222.8% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from ZyVersa Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), ZyVersa Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 3,042.8%.
  • Historical annual values: Fiscal year 2025: 8.10 million shares | Fiscal year 2024: 2.51 million shares | Fiscal year 2023: 402,205 shares | Fiscal year 2022: 257,604 shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: